{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:56:32Z","timestamp":1787313392614,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cca.2024.119928","type":"journal-article","created":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T01:27:36Z","timestamp":1723944456000},"page":"119928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Integrating pretest probability for rheumatoid arthritis with likelihood ratios of RF and ACPA to improve clinical utility of rheumatoid arthritis autoantibody testing"],"prefix":"10.1016","volume":"564","author":[{"given":"Daphn\u00e9","family":"Vandebeek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Lodewijckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"Van Hoovels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Verschueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6856-8485","authenticated-orcid":false,"given":"Xavier","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2024.119928_b0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.semarthrit.2006.08.006","article-title":"Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review","volume":"36","author":"Alamanos","year":"2006","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.cca.2024.119928_b0010","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: A review","volume":"320","author":"Aletaha","year":"2018","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.cca.2024.119928_b0015","first-page":"689","article-title":"Etiology and risk factors for rheumatoid arthritis: A state-of-the-art review","volume":"8","author":"Rom\u00e3o","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.cca.2024.119928_b0020","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2024.119928_b0025","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2024.119928_b0030","first-page":"1245","article-title":"Diagnosis and management of rheumatoid arthritis","volume":"84","author":"Wasserman","year":"2011","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.cca.2024.119928_b0035","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid Arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cca.2024.119928_b0040","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0000000000001013","article-title":"Rheumatoid arthritis: prediction of future clinically-apparent disease, and prevention","volume":"36","author":"Deane","year":"2024","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cca.2024.119928_b0045","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/annrheumdis-2012-203130","article-title":"What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review","volume":"73","author":"van Nies","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2024.119928_b0050","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0000000000001006","article-title":"Autoantibodies in rheumatoid arthritis \u2013 rheumatoid factor, anticitrullinated protein antibodies and beyond","volume":"36","author":"Steiner","year":"2024","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cca.2024.119928_b0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/annrheumdis-2017-212365","article-title":"Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR\/EULAR classification of rheumatoid arthritis","volume":"77","author":"Van Hoovels","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2024.119928_b0060","doi-asserted-by":"crossref","first-page":"e002099","DOI":"10.1136\/rmdopen-2021-002099","article-title":"Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein\/peptide antibodies test results","volume":"8","author":"Van Hoovels","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.cca.2024.119928_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102405","article-title":"Precision medicine and management of rheumatoid arthritis","volume":"110","author":"Aletaha","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cca.2024.119928_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2022.100142","article-title":"Impact of autoimmune serology test results on RA classification and diagnosis","volume":"5","author":"Van Hoovels","year":"2022","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.cca.2024.119928_b0075","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/jalm\/jfaa064","article-title":"Likelihood ratios as value proposition for diagnostic laboratory tests","volume":"5","author":"Fierz","year":"2020","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.cca.2024.119928_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655262","article-title":"Likelihood ratio approach and clinical interpretation of laboratory tests","volume":"12","author":"Fierz","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2024.119928_b0085","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an american college of rheumatology\/European league against rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2024.119928_b0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/annrheumdis-2016-209846","article-title":"EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis","volume":"76","author":"van Steenbergen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2024.119928_b0095","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/ar2832","article-title":"The prognostic value of baseline erosions in undifferentiated arthritis","volume":"11","author":"Thabet","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2024.119928_b0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","article-title":"Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cca.2024.119928_b0105","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/archinternmed.2010.84","article-title":"Comparative analysis of different approaches to report diagnostic accuracy","volume":"170","author":"Vermeersch","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cca.2024.119928_b0110","doi-asserted-by":"crossref","unstructured":"American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction.Arthritis Rheum 2002; 47: 429-433.","DOI":"10.1002\/art.10381"},{"key":"10.1016\/j.cca.2024.119928_b0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2024.119928_b0120","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3390\/healthcare9121726","article-title":"Defining the optimal strategies for achieving drug-free remission in rheumatoid arthritis: A narrative review","volume":"9","author":"Gul","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.cca.2024.119928_b0125","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/art.39297","article-title":"Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease","volume":"67","author":"Ramos-Remus","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.cca.2024.119928_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.685312","article-title":"Autoantibodies in rheumatoid arthritis - laboratory and clinical perspectives","volume":"12","author":"R\u00f6nnelid","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124021818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124021818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T09:46:57Z","timestamp":1725356817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124021818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":26,"alternative-id":["S0009898124021818"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.119928","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating pretest probability for rheumatoid arthritis with likelihood ratios of RF and ACPA to improve clinical utility of rheumatoid arthritis autoantibody testing","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.119928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119928"}}